Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T18:48:09.672Z.
Calculation as of: 2026-10-06T18:48:09.672Z.
Quote observation: 2026-10-06T18:44:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b7fd3b5d8e417d78924f6cd313032c2aac5600bd184120b35a4860f29c1b1599
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tiziana Life Sciences Ltd (TLSA) | $68.40M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 1.00 | 1.59 | 0.87 | 1.13 |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | 1.12 | 1.46 | 1.57 | 1.74 |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 1.62 | 2.77 | 1.68 | 6.38 |
| Cingulate Inc. (CING)vs › | $67.01M | N/A | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $66.28M | 662.81 | 543.83 | 239.20 | 162.97 |
| XBiotech Inc. (XBIT)vs › | $66.16M | N/A | 200.05 | 76.23 | 64.81 |
| MindWalk Holdings Corp. (HYFT)vs › | $71.36M | 6.09 | 5.20 | 3.12 | 4.32 |
| Gossamer Bio, Inc. (GOSS)vs › | $64.53M | 1.21 | 6.22 | 5.05 | 5.05 |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.16M | 2.38 | 2.63 | 18.18 | 35.41 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
